Background Current endoscopic therapy for neoplastic Barrett's oesophagus (BO) consists
of complete resection/ablation of all Barrett's tissue including neoplastic lesions. Recurrence …

Background & Aims Barrett's esophagus (BE) with high-grade dysplasia (HGD) or
intramucosal carcinoma (IMC) is treated by complete eradication of areas of BE by …

Evaluation of: Lopes CV, Hela M, Pesenti C et al. Circumferential endoscopic resection of
Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg. Endosc. 21 …

In the past 2 decades, endoscopic therapy has been proven to be an effective, safe, and
minimally invasive alternative to surgery for Barrett's esophagus (BE) with early neoplasia …

METHODS: This was a single-center retrospective study of adult patients that underwent
EMR and ESD for the treatment of dysplastic Barrett's esophagus and non-invasive …

Background Barrett's oesophagus (BE) is a pre-malignant condition leading to oesophageal
adenocarcinoma (OAC). Treatment of neoplasia at an early stage is desirable. Combined …

Background: Endoscopic eradication therapy (EET) combining endoscopic resection (ER)
with endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) …

Endoscopic therapy has largely replaced esophagectomy in the management of neoplastic
lesions [high grade dysplasia (HGD) and early cancer] in patients with Barrett's esophagus …

Endotherapy (resection of visible lesions followed by ablation) is now firmly established as a
first-line treatment option in subjects with Barrett's esophagus (BE)-related dysplasia and …

Abstract Background Although Endoscopic Submucosal Dissection (ESD) was proven
superior to Endoscopic Mucosal Resection (EMR) in achieving higher complete remission …